Bio-Techne (TECH) Revenue (2009 - 2026)

Bio-Techne's Revenue history runs 18 years deep, the most recent figure standing at $311.4 million for Q1 2026.

• On a quarterly basis, Revenue fell 1.51% year-over-year to $311.4 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 0.17% change from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 5.23% from the prior year.
• Revenue rose to $311.4 million in Q1 2026 per TECH's latest filing, from $295.9 million in the prior quarter.
• Across five years, Revenue topped out at $317.0 million in Q2 2025 and bottomed at $2.0 million in Q3 2022.
• The 5-year median for Revenue is $294.1 million (2023), against an average of $277.7 million.
• Across the five-year window, Revenue tumbled 99.22% in 2022 and surged 13746.75% in 2023, its largest moves.
• Year by year, Revenue stood at $271.6 million in 2022, then increased by 0.37% to $272.6 million in 2023, then advanced by 8.96% to $297.0 million in 2024, then retreated by 0.39% to $295.9 million in 2025, then rose by 5.25% to $311.4 million in 2026.
• Per Business Quant, the three latest TECH Revenue figures stand at $311.4 million (Q1 2026), $295.9 million (Q4 2025), and $286.6 million (Q3 2025).